Monday, July 31, 2017 9:12:40 PM
Marc Tesio is an experienced investment banker who has successfully raised in excess of $50 million of capital for life sciences and other companies. Most recently, he managed a registered direct public offering for Dara Biosciences, Inc., a life science company developing therapeutic treatments for diseases including diabetes. He also acted as financial advisor to ResverLogix, a Canadian biotechnology company that is developing two novel technologies for important global medical markets, and managed a early stage life science investment for Digene Corporation. Prior to his activities in healthcare corporate finance he managed a syndicate desk and oversaw trading and settlements serving international banks and European based institutional portfolio managers. He began his career at Oppenheimer. He holds a degree with honors in Financial Management from Old Dominion University. He serves his local community helping non-profit organizations and enjoys amateur Georgia State athletic competitions and his family in Atlanta. He holds the Series 7, 24, 63 and 79 securities licenses.
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM